MEDANTA Stock Overview
Global Health Limited engages in the provision of healthcare services in India.
Notes are coming soon
Global Health Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹438.45|
|52 Week High||₹487.75|
|52 Week Low||₹390.55|
|1 Month Change||-4.12%|
|3 Month Change||n/a|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||5.57%|
Recent News & Updates
|MEDANTA||IN Healthcare||IN Market|
Return vs Industry: Insufficient data to determine how MEDANTA performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how MEDANTA performed against the Indian Market.
|MEDANTA Average Weekly Movement||3.7%|
|Healthcare Industry Average Movement||4.9%|
|Market Average Movement||5.7%|
|10% most volatile stocks in IN Market||9.0%|
|10% least volatile stocks in IN Market||3.3%|
Stable Share Price: MEDANTA is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: Insufficient data to determine MEDANTA's volatility change over the past year.
About the Company
Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, musculoskeletal disorders and orthopedics, critical care and anesthesiology, gastroenterology, endocrinology and diabetology, nephrology, obstetrics and gynecology, dermatology, ophthalmology, dental, lung and liver transplant, kidney and urology, and various specializations, as well as ayurvedic medicine. It operates a network of four hospitals in Gurugram, Delhi, Indore, Ranchi, Patna, and Lucknow under the Medanta brand.
Global Health Limited Fundamentals Summary
|MEDANTA fundamental statistics|
Is MEDANTA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MEDANTA income statement (TTM)|
|Cost of Revenue||₹12.16b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 13, 2023
|Earnings per share (EPS)||7.95|
|Net Profit Margin||9.25%|
How did MEDANTA perform over the long term?See historical performance and comparison